Priyanka Garg | Health and Medicine | Best Researcher Award

Published on by New Scientists

Ms. Priyanka Garg | Health and Medicine | Best Researcher Award

Assistant Professor, Lovely Professional University, India

Ms. Priyanka Garg is currently serving as an Assistant Professor at the School of Pharmaceutical Sciences, Lovely Professional University (LPU), Punjab, India, where she contributes actively to academic instruction, clinical research, and student mentorship. She holds an M.Pharm in Pharmacy Practice (2022) and a B.Pharm (2020), both from Lovely Professional University, with specialization in pharmacotherapy, pharmacovigilance, and patient-centered care. Her primary research interests encompass pharmacogenomics, clinical pharmacology, women’s health, chronic disease management, and the role of gut microbiota in metabolic disorders, with emerging work focusing on personalized medicine for PCOS and Ehlers-Danlos Syndrome. Professionally, she has served at LPU since January 2023 and previously trained at Shiva Biogenetic Pharmaceuticals Pvt. Ltd. and Doaba Hospital Pvt. Ltd., where she gained practical expertise in manufacturing, IPQC, patient monitoring, and clinical data analysis. Her key contributions include two granted copyrights—“Laboratory and Clinical Result for Polycystic Ovary Syndrome” (2024) and “Clinical Findings for Ehlers-Danlos Syndrome” (2025)—and several impactful presentations at national and international conferences such as SHE-SCIENCE 2025 and the International Conference of Pharmacy series. She has published indexed research in reputed journals including Obesity Medicine and Human Gene. Her scholarly influence is reflected through her author metrics: 3 documents, 25 citations and an h-index of 2. Among her awards and honors, she was recognized for her publication on Type 2 Diabetes Mellitus and Quality of Life (2022) and received accolades for her leadership roles as Faculty Coordinator and Organizing Committee Member for major scientific events at LPU. Additionally, she serves as a Reviewer for the Population Medicine Journal and engages in academic outreach, environmental awareness, and student development programs. Through her interdisciplinary research and commitment to education, Ms. Priyanka Garg aims to advance pharmacogenomics-based therapeutic strategies and promote evidence-driven healthcare innovation that bridges scientific discovery with societal impact.

Profile: Scopus | ORCID | ResearchGate

Featured Publications

1. Garg, P., & Yanadaiah, P. (2025). Assessment of quality of life among type 2 diabetes mellitus and hypertensive patients in Punjab region: A WHOQoL-BREF based hospital study. Obesity Medicine, 58, 100651.

2. Garg, P., Jallepalli, V. R., & Verma, S. (2024). Unravelling the CXCL12/CXCR4 axis in breast cancer: Insights into metastasis, microenvironment interactions, and therapeutic opportunities. Human Gene, 40, 201272.

3. Garg, P., & Duggal, N. (2022). Type 2 diabetes mellitus, its impact on quality of life and how the disease can be managed–A review. Obesity Medicine, 35, 100459.

 

Paul Padovani | Health and Medicine | Best Researcher Award

Published on by New Scientists

Dr. Paul Padovani | Health and Medicine | Best Researcher Award

Pediatric cardiologist, University Hospital of Nantes, France

Dr. Paul Padovani is a Junior Doctor in Pediatric and Congenital Cardiology (MD, MSc in Clinical Research) at Nantes University Hospital (CHU de Nantes), France, where he integrates clinical practice, research, and digital health innovation to enhance outcomes for children with congenital heart disease. He earned his MD and MSc in Clinical Research, completing specialized cardiovascular medicine training after ranking 372nd in the French National Exam (ECN), with rotations in leading French university hospitals. His research focuses on pediatric and congenital interventional cardiology, quality-of-life assessment and exercise physiology in CHD, simulation-based medical education, and the development of AI/NLP pipelines integrated with OMOP Common Data Model (CDM) to enable structured healthcare data analysis. Professionally, he has contributed to over ten major research projects, including QUALISYSTEMIC, the first nationwide study on systemic right ventricle quality of life, and SIMUL-CHD, a randomized controlled trial on simulation-based communication training, while also leading AI-driven multicenter data initiatives. Dr. Paul Padovani has published 14 peer-reviewed articles, achieving 56 citations and an h-index of 4, reflecting his emerging impact in pediatric cardiology and digital health. He has received competitive research grants and recognition for advancing multicenter clinical studies and digital health programs. He is an active member of the French Society of Pediatric Cardiology (SFCP) and the Association for European Paediatric and Congenital Cardiology (AEPC), participating in international collaborations and peer-reviewed research efforts. His skills encompass clinical trial design, pediatric interventional procedures, simulation-based education, quality-of-life assessments, and AI-enabled data integration. Dr. Paul Padovani’s vision is to bridge clinical innovation, research, and education, improving patient outcomes, fostering reproducible research, and mentoring future leaders. His work is transforming pediatric cardiology, advancing digital health solutions, and establishing him as a globally recognized emerging leader in health and medicine.

Profile: Scopus | ORCID | ResearchGate | Sci Profiles | Scilit | LinkedIn

Featured Publications

1. Padovani, P., Singh, Y., Pass, R. H., Vasile, C. M., Nield, L. E., & Baruteau, A.-E. (2023). E-health: A game changer in fetal and neonatal cardiology? Journal of Clinical Medicine, 12(21), 6865.

2. Vasile, C. M., Padovani, P., Rujinski, S. D., Nicolosu, D., Toma, C., Turcu, A. A., & Cioboata, R. (2023). The increase in childhood obesity and its association with hypertension during pandemics. Journal of Clinical Medicine, 12(18), 5909.

3. Dardari, M., Iorgulescu, C., Bataila, V., Deaconu, A., Cinteza, E., Vatasescu, R., Padovani, P., Vasile, C. M., & Dorobantu, M. (2023). Transvenous lead extraction in a European low-volume center without on-site surgical support. Reports, 6(3), 41.

4. Dardari, M., Cinteza, E., Vasile, C. M., Padovani, P., & Vatasescu, R. (2023). Infective endocarditis among pediatric patients with prosthetic valves and cardiac devices: A review and update of recent emerging diagnostic and management strategies. Journal of Clinical Medicine, 12(15), 4941.

5. Padovani, P., Grunenwald Gronier, C., & Baruteau, A.-E. (2023). Midline crossing right pulmonary veins with dual drainage to the left atrium. Cardiology in the Young, 33(2), 305–308.

 

Yiling Hou | Health and Medicine | Best Researcher Award

Published on by New Scientists

Prof. Dr. Yiling Hou | Health and Medicine | Best Researcher Award

Professor, China West Normal University, China

Prof. Dr. Yiling Hou is a distinguished scientist and Professor at the College of Life Sciences, China West Normal University, recognized as a reserve candidate for academic and technological leadership in Sichuan Province and an overseas high-level talent. She earned her Bachelor of Science in Pharmacy (2005) and Master of Science in Medicinal Chemistry (2008) from Sichuan University, followed by a Doctor of Science in Biochemistry and Molecular Biology (2011) from Sichuan Agricultural University and further enhanced her expertise as a visiting scholar at the Perelman School of Medicine, University of Pennsylvania (2017–2018). Beginning her career as a Teaching Assistant in 2008, she advanced to Lecturer in 2011, Associate Professor in 2011 and full Professor in 2016, also serving as Program Director for Biotechnology (2013–2020) and currently as Deputy Director of the Sichuan Collaborative Innovation Center for Tissue Repair Materials Engineering Technology. Her research focuses on the isolation, purification, structural identification and biological activity of fungal polysaccharides, alongside tumor cell kinetics, spindle dynamics during mitosis, meiosis and the molecular mechanisms underlying cancer progression. Skilled in structural identification, molecular medicine, apoptosis analysis and advanced biopharmaceutical techniques, she has published 104 Scopus-indexed papers with 787 citations and an h-index of 16, reflecting her growing international impact. Prof. Dr. Yiling Hou is an active Councilor of the Sichuan Provincial Microbiology Society and the Sichuan Provincial Youth Federation, highlighting her commitment to scientific community leadership and youth engagement. Honored as an emerging academic leader in Sichuan Province, she continues to guide students and collaborative projects that bridge traditional pharmacology and modern oncology. With her strong publication record, leadership roles and global collaborations, Prof. Dr. Yiling Hou is poised to make transformative contributions to cancer research and molecular therapeutics, advancing biomedical science and inspiring future generations of researchers.

Profile: Scopus | ResearchGate | Sci Profiles | Scilit

Featured Publications

1. Wang, Y., Lu, R., Ding, X., You, Y., Lin, Y., Hou, Y., & Xia, Y. (2025). Structure identification and in vitro immunomodulatory activities of polysaccharide AHL26-P from Arachis hypogaea (Tianfu 26) leaves. Results in Chemistry, 18, 102724.

2. Sun, Z.-A., Zhao, N., Zheng, L., Pan, F., Ding, X., & Hou, Y. (2025, June 26). Comparative studies on the structure and biological activities of two new polysaccharides from Tricholoma flavovirens (TF-P) and Trametes versicolor (TV-P). Results in Chemistry. Advance online publication.

3. Liu, K., Sun, Z., Li, X., Qing, X., Yu, W., Liu, M., Ding, X., & Hou, Y. (2025). Structure characterization and biological activity of polysaccharides from Trametes sanguinea (TS-P) and wild Lentinus edodes (LE-P). Food Bioscience, 68, 106656.

4. Zhou, L., Ding, X., & Hou, Y. (2024). The structure characterization and biological activities of new polysaccharides from Armillariella tabescens (AT-P) and Tricholoma portentosum (TP-P). Results in Chemistry, 18, 4620–4633.

5. Yu, W., Yuan, R., Liu, M., Liu, K., Ding, X., & Hou, Y. (2024). Effects of rpl1001 gene deletion on cell division of fission yeast and its molecular mechanism. Current Issues in Molecular Biology, 46(3), 2576–2597.